Skandinaviska Enskilda Banken (SEB)
CRL icon

Skandinaviska Enskilda Banken (SEB)’s Charles River Laboratories CRL Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75
Closed -$11.7K – 737
2025
Q3 		$11.7K Sell
75
-69
-48% -$11K ﹤0.01% 770
2025
Q2 		$21.8K Hold
144
– – ﹤0.01% 820
2025
Q1 		$21.7K Sell
144
-9,144
-98% -$1.53M ﹤0.01% 798
2024
Q4 		$1.7M Hold
9,288
– – 0.01% 600
2024
Q3 		$1.83M Sell
9,288
-64,095
-87% -$13.3M 0.01% 602
2024
Q2 		$15.2M Sell
73,383
-37,781
-34% -$8.56M 0.07% 204
2024
Q1 		$30.1M Sell
111,164
-297
-0.3% -$70.9K 0.15% 124
2023
Q4 		$26.3M Hold
111,461
– – 0.15% 132
2023
Q3 		$21.8M Sell
111,461
-23
-0% -$4.72K 0.14% 145
2023
Q2 		$23.4M Sell
111,484
-2,480
-2% -$493K 0.15% 135
2023
Q1 		$23M Sell
113,964
-793
-0.7% -$180K 0.16% 135
2022
Q4 		$25M Buy
114,757
+570
+0.5% +$124K 0.19% 124
2022
Q3 		$22.5M Buy
114,187
+19,577
+21% +$4.23M 0.17% 122
2022
Q2 		$20.2M Buy
94,610
+13,889
+17% +$3.39M 0.15% 139
2022
Q1 		$22.9M Buy
80,721
+10,207
+14% +$3.15M 0.13% 146
2021
Q4 		$26.5M Sell
70,514
-7,568
-10% -$2.94M 0.14% 143
2021
Q3 		$32.2M Buy
78,082
+64,665
+482% +$26.9M 0.18% 128
2021
Q2 		$4.96M Buy
13,417
+7,911
+144% +$2.64M 0.03% 423
2021
Q1 		$1.6M Buy
5,506
+336
+6% +$93.4K 0.01% 723
2020
Q4 		$1.29M Sell
5,170
-277
-5% -$66K 0.01% 762
2020
Q3 		$1.23M Buy
5,447
+5,324
+4,328% +$1.1M 0.01% 688
2020
Q2 		$21K Buy
+123
New +$19.6K ﹤0.01% 1015

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s CRL Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 75 shares — an estimated $11.7K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CRL in Q2 2020 and held it in 22 quarters. The position peaked at $32.2M in Q3 2021. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 75 Charles River Laboratories shares in Q4 2025, an estimated $11.7K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Charles River Laboratories in Q2 2020 and held it in 22 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Charles River Laboratories position peaked at $32.2M in Q3 2021.
  • 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.